Medicine and Dentistry
Patient
60%
Pediatrics Patient
40%
Classical Hodgkin Lymphoma
40%
Marker
40%
Prospective Study
30%
Therapeutic Procedure
30%
Plasma
30%
Treatment Response
20%
Biological Marker
20%
Spontaneous Remission
20%
Positron Emission Tomography
10%
Progression Free Survival
10%
Diagnosis
10%
Enzyme Linked Immunosorbent Assay
10%
Interim Analysis
10%
Hodgkin's Lymphoma
10%
Microenvironment
10%
Progressive Disease
10%
Cells
10%
Assessment
10%
Blood
10%
Nursing and Health Professions
Marker
40%
Chemotherapy
30%
Biological Marker
20%
Treatment Response
20%
Remission
20%
Adult
20%
Pediatrics
20%
Pilot Study
10%
Progression Free Survival
10%
Diagnosis
10%
Enzyme Linked Immunosorbent Assay
10%
Hodgkin Disease
10%
Contrast
10%
Immunology and Microbiology
Thymus and Activation Regulated Chemokine
100%
Blood Plasma
30%
Blood Product
10%
Progression Free Survival
10%
ELISA
10%
Cells
10%
Contrast
10%
Positron Emission Tomography
10%
Reed Sternberg Cell
10%
Pharmacology, Toxicology and Pharmaceutical Science
Thymus and Activation Regulated Chemokine
100%
Classical Hodgkin Lymphoma
40%
Biological Marker
20%
Remission
20%
Progression Free Survival
10%
Hodgkin Disease
10%
Biochemistry, Genetics and Molecular Biology
Pediatrics
40%
Positron Emission Tomography
10%
Progression Free Survival
10%
Contrast
10%